Company news

EMV Capital PLC news in 2024

EMV Capital PLC's news releases, calls and decks from 2024, newest first.

View company

Grant of Share Options

December 31, 2024

Q-Bot Fundraising

December 31, 2024

Wanda Health Fundraising

December 9, 2024

Close of Fundraising and Result of Retail Offer

December 5, 2024

Result of Subscription

December 3, 2024

WRAP Retail Offer

December 3, 2024

Proposed Subscription and Retail Offer; Update

December 3, 2024

Replacement RNS: PDS: Update, 3rd Quarter Results

November 14, 2024

PDS: Clinical Programs Update, 3rd Quarter Results

November 14, 2024

PDS: 36-Month Overall Survival Rate announcement

October 2, 2024

Interim Results

September 30, 2024

Name change and AIM Rule 26 website

September 26, 2024

PDS: Updated Results, VERSATILE-002 Phase 2 Trial

September 16, 2024

PDS Biotech: Business Update and Q2 2024 Results

August 13, 2024

Replacement RNS: PDS Biotech Aligns with FDA

August 2, 2024

PDS Biotech Aligns with FDA on Phase 3 Trial

August 2, 2024

Notice of AGM

June 18, 2024

Preliminary Results for the year ended 31 Dec 2023

June 13, 2024

Notice of Results and Investor Presentation

May 31, 2024

DeepTech Recycling: Fundraising, Business Update

May 31, 2024

Investment in Wanda, related party transactions

May 28, 2024

PDS Biotech: Business Update and Q1 2024 Results

May 15, 2024

Martlet Capital: mandate and acquisition

May 13, 2024

PDS Biotech: Clinical trial meets study endpoints

May 10, 2024

ProAxsis secures c.£1.8mn investment

April 15, 2024

PDS Strategy Update and 2023 Financial Results

March 27, 2024

Business Update

March 13, 2024

Exercise of Options and Issue of Shares

February 5, 2024

Glycotest secures $1 million investment

January 23, 2024

Calls in 2024

Decks in 2024